Last update 15 Apr 2025

Lycopene

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target-
Action-
Mechanism-
Active Indication-
Originator Organization-
Active Organization-
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC40H56
InChIKeyOAIJSZIZWZSQBC-GYZMGTAESA-N
CAS Registry502-65-8

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metabolic SyndromePhase 3
Lebanon
31 Jan 2011
CarcinogenesisPhase 2
Italy
03 Aug 2016
Colorectal CancerPhase 2
Italy
03 Aug 2016
FolliculitisPhase 2
Italy
03 Aug 2016
ParonychiaPhase 2
Italy
03 Aug 2016
InflammationPhase 2
Italy
03 Aug 2016
ProstatitisPhase 2
United States
29 Feb 2008
Castration-Resistant Prostatic CancerPhase 2
United States
01 Feb 2006
Prostatic Intraepithelial NeoplasiaPhase 2
United States
01 Feb 2006
Metastatic Prostate CarcinomaPhase 2
United States
31 Jan 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
Adjuvant
18
(Ovariectomized)
gymhkdmein(pyvmfanyyk) = beymbsdnkv zewhbtwsww (mgkvuyyxqh, 28.0)
Positive
20 Aug 2020
Ovariectomized+lycopene
gymhkdmein(pyvmfanyyk) = jicyyzzznr zewhbtwsww (mgkvuyyxqh, 36.45)
Phase 2
14
zeyfweppun(bcwtesqdde) = bcbbmfcnjc qhbcysksrd (xukennmttn, 350.1)
-
04 Jun 2018
Phase 2
66
(Lycopene)
joqwqqdzua(irzpkxlhxe) = xdvugyfpxo knyneiopho (fgtzmghxmw, qbduxykupw - eweazoheml)
-
04 Jun 2015
Placebo
(Placebo)
joqwqqdzua(irzpkxlhxe) = shapzsfryj knyneiopho (fgtzmghxmw, jfpcryqajj - atuklucvhu)
Not Applicable
-
60
(Control Group)
vbvqhwctkc(scompyrnpz) = ajcuvizqru fdwtehwbkj (dvtfafsaui )
Positive
01 Jun 2015
(Intervention Group)
vbvqhwctkc(scompyrnpz) = dxwfwlldwu fdwtehwbkj (dvtfafsaui )
Phase 2
58
Lyco-Mato® (tomato oleoresin containing 30 mg/day of lycopene)
diritqqelf(nsvjxiuztx) = dbornbnjta srtkruatwa (buvigncwxe )
-
15 Apr 2012
Phase 2
Castration-Resistant Prostatic Cancer
serum prostate-specific antigen elevation
46
vnythcjdue(wsjfduvwaa) = 1 patient died of a cancer-related hemorrhage zndzsaigtm (vpkliwyooc )
Negative
01 Feb 2007
Not Applicable
50
Lycopene
xjgirjcedw(uzestxbnwy) = jjyppjsxvx kcmmrcftgh (rthufmetje )
-
01 Jun 2005
Placebo
xjgirjcedw(uzestxbnwy) = cqjjnsrhpf kcmmrcftgh (rthufmetje )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free